Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 5, 1998

View Archived Issues

3M presents first clinical results for potent new immunomodulator

Genome Therapeutics and ArQule begin high-throughput screening

Elan reacquires Naprelan and Verelan rights from Wyeth-Ayerst

U.S. is country of first launch for DuPont's NNRTI

PathoGenesis in-licenses monobactam antibiotic from Bristol-Myers Squibb

Linezolid in the limelight at ICAAC

Nonimmunosuppressive rotamase inhibitors under study at Guilford for neurological disorders

BASF describes novel inhibitors of cysteine proteases

Canadian team isolates novel anti-HSV agent from Chinese herb

Novel anti-HBV nucleosides presented by Nabi at ICAAC

Merck KGaA, 3DP extend drug discovery agreement for another year

CP-279107 inhibits macrolide-resistant streptococci in vitro and in vivo

Versicor searches for inhibitors of bacterial ligases as novel antibiotics

NC-1175: novel conjugated styryl ketone with ATPase-targeted fungicidal activity

New collaboration into the genetic basis of obesity announced

Bisphosphonate-conjugated antibacterials for targeted drug delivery in bone infections

SmithKline Beecham acquires transdermal nicotine product in Australia and New Zealand

Merck describes new ascomycin derivatives with improved therapeutic potential

Chiroscience identifies new target for autoimmune disease therapy

FDA approves anthracycline with orphan drug status for carcinoma in situ of the bladder

Study suggests beneficial effects of COX-2 inhibition in cerebral ischemia

Preliminary phase II data and preclinical results reported for MK-826

Penederm joins the Mylan family of companies

Bayer's moxifloxacin highlighted at ICAAC; approval to be sought soon

Candidate gene therapy for hemophilia gives promising results in canine studies

Italian marketing approval obtained for metoclopramide nasal spray

Inex, Schwarz drop development of antisense drug for restenosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...